NASDAQ : TCRT
Alaunos Therapeutics, Inc. — Financial statements
Healthcare · Biotechnology · United States
Last price 1.95 USD (Oct 30, 2026, 4:00 PM EST) · Market cap 4.95M
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Financial statements
Alaunos Therapeutics, Inc. (TCRT) reported revenue of 3.00K USD (TTM). Five years of income statement, balance sheet, cash flow and ratios below.
Income statement
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Revenue | 3.00K | 5.00K | 10.00K | 5.00K | 2.92M | 398.00K |
| Cost of Revenue | 1.65M | 1.36M | 362.00K | 16.28M | 22.52M | 47.27M |
| Gross Profit | -1.64M | -1.36M | -352.00K | -16.27M | -19.60M | -46.88M |
| Selling, General & Admin | 2.41M | 2.87M | 4.46M | 12.22M | 13.14M | 26.27M |
| Operating Expenses | 2.41M | 2.87M | 4.46M | 12.22M | 13.14M | 26.27M |
| Operating Income | -4.06M | -4.22M | -4.81M | -28.49M | -32.74M | -73.15M |
| Interest Expense | -1.92M | -3.15M | -1.19M | |||
| Other Non Operating Income (Expenses) | 47.00K | 49.00K | 133.00K | 1.05M | 529.00K | -13.00K |
| EBT Excluding Unusual Items | -4.01M | -4.18M | -4.68M | -29.37M | -35.36M | -74.35M |
| Merger & Restructuring Charges | -1.27M | -3.66M | ||||
| Asset Writedown | -4.80M | -740.00K | ||||
| Other Unusual Items | 298.00K | -2.37M | ||||
| Pretax Income | -4.01M | -4.18M | -4.68M | -35.14M | -37.73M | -78.75M |
| Net Income | -4.01M | -4.18M | -4.68M | -35.14M | -37.73M | -78.75M |
| Preferred Dividends & Other Adjustments | 106.00K | 106.00K | ||||
| Net Income to Common | -4.12M | -4.28M | -4.68M | -35.14M | -37.73M | -78.75M |
| Shares Outstanding (Basic) | 2.33M | 1.95M | 1.60M | 1.60M | 1.45M | 1.43M |
| Shares Outstanding (Diluted) | 2.33M | 1.95M | 1.60M | 1.60M | 1.45M | 1.43M |
| EPS (Basic) | -1.77 | -2.20 | -2.92 | -21.97 | -26.07 | -55.10 |
| EPS (Diluted) | -1.77 | -2.20 | -2.92 | -21.97 | -26.10 | -55.10 |
| Free Cash Flow | -2.83M | -2.97M | -4.97M | -30.34M | -29.45M | -64.79M |
| Free Cash Flow Per Share | -1.21 | -1.52 | -3.10 | -18.97 | -20.34 | -45.33 |
| Operating Margin | -135,233.33% | -84,500.00% | -48,120.00% | -569,860.00% | -1,120.40% | -18,379.90% |
| Profit Margin | -137,200.00% | -85,640.00% | -46,790.00% | -702,800.00% | -1,291.24% | -19,786.68% |
| Free Cash Flow Margin | -94,166.67% | -59,340.00% | -49,710.00% | -606,780.00% | -1,007.80% | -16,279.15% |
| EBITDA | -4.03M | -4.22M | -4.81M | -26.18M | -29.98M | -70.56M |
| D&A For EBITDA | 23.00K | 7.00K | 2.00K | 2.31M | 2.76M | 2.60M |
| EBIT | -4.06M | -4.22M | -4.81M | -28.49M | -32.74M | -73.15M |
Balance sheet
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Cash & Equivalents | 124.00K | 1.39M | 1.09M | 6.06M | 39.06M | 76.05M |
| Cash & Short-Term Investments | 124.00K | 1.39M | 1.09M | 6.06M | 39.06M | 76.05M |
| Accounts Receivable | 3.00K | 5.00K | 1.00K | 4.00K | 1.11M | |
| Receivables | 3.00K | 5.00K | 1.00K | 4.00K | 1.11M | |
| Prepaid Expenses | 320.00K | 378.00K | 1.66M | 2.20M | 799.00K | 1.67M |
| Restricted Cash | 13.94M | |||||
| Other Current Assets | 222.00K | 222.00K | ||||
| Total Current Assets | 666.00K | 1.99M | 2.75M | 8.26M | 53.80M | 78.83M |
| Property, Plant & Equipment | 74.00K | 91.00K | 2.00K | 10.60M | 15.36M | |
| Long-Term Deferred Charges | 776.00K | 887.00K | ||||
| Other Long-Term Assets | 542.00K | 673.00K | ||||
| Total Assets | 1.52M | 2.97M | 2.75M | 8.26M | 64.94M | 94.86M |
| Accounts Payable | 732.00K | 613.00K | 516.00K | 616.00K | 1.39M | 1.37M |
| Accrued Expenses | 132.00K | 200.00K | 176.00K | 1.34M | 5.45M | 6.08M |
| Current Portion of Long-Term Debt | 16.77M | 7.87M | ||||
| Current Portion of Leases | 558.00K | 729.00K | ||||
| Total Current Liabilities | 864.00K | 813.00K | 692.00K | 1.96M | 24.17M | 16.04M |
| Long-Term Debt | 16.25M | |||||
| Long-Term Leases | 2.19M | 4.52M | ||||
| Other Long-Term Liabilities | 28.00K | -1.00K | ||||
| Total Liabilities | 864.00K | 813.00K | 692.00K | 1.96M | 26.38M | 36.81M |
| Common Stock | 2.00K | 2.00K | 2.00K | 2.00K | 16.00K | 216.00K |
| Additional Paid-In Capital | 927.23M | 926.77M | 922.51M | 922.07M | 919.17M | 900.69M |
| Retained Earnings | -926.58M | -924.62M | -920.45M | -915.77M | -880.63M | -842.85M |
| Total Common Equity | 652.00K | 2.15M | 2.06M | 6.31M | 38.55M | 58.06M |
| Shareholders' Equity | 652.00K | 2.15M | 2.06M | 6.31M | 38.55M | 58.06M |
| Total Liabilities & Equity | 1.52M | 2.97M | 2.75M | 8.26M | 64.94M | 94.86M |
| Total Debt | 19.51M | 29.36M | ||||
| Net Cash (Debt) | 124.00K | 1.39M | 1.09M | 6.06M | 19.55M | 46.69M |
| Net Cash Per Share | 0.05 | 0.71 | 0.68 | 3.79 | 13.50 | 32.66 |
| Filing Date Shares Outstanding | 2.54M | 2.38M | 1.60M | 1.60M | 1.60M | 1.43M |
| Total Common Shares Outstanding | 2.49M | 2.35M | 1.60M | 1.60M | 1.60M | 1.43M |
| Working Capital | -198.00K | 1.18M | 2.06M | 6.30M | 29.63M | 62.79M |
| Book Value Per Share | 0.26 | 0.92 | 1.29 | 3.94 | 24.15 | 40.52 |
| Tangible Book Value | 652.00K | 2.15M | 2.06M | 6.31M | 38.55M | 58.06M |
| Tangible Book Value Per Share | 0.26 | 0.92 | 1.29 | 3.94 | 24.15 | 40.52 |
| Machinery | 98.00K | 15.00K | 15.00K | 7.42M | 7.64M | |
| Leasehold Improvements | 9.56M | 9.47M |
Cash flow statement
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Net Income | -4.01M | -4.18M | -4.68M | -35.14M | -37.73M | -78.75M |
| Depreciation & Amortization | 24.00K | 7.00K | 2.00K | 2.31M | 2.76M | 2.60M |
| Other Amortization | 1.34M | 981.00K | 383.00K | |||
| Loss (Gain) From Sale of Assets | 7.00K | 7.00K | ||||
| Asset Writedown & Restructuring Costs | 4.80M | 740.00K | ||||
| Stock-Based Compensation | 550.00K | 414.00K | 435.00K | 2.80M | 3.53M | 10.77M |
| Other Operating Activities | 382.00K | 413.00K | -12.00K | 353.00K | -352.00K | |
| Change in Accounts Receivable | 2.00K | 2.00K | -4.00K | 3.00K | 1.11M | 3.56M |
| Change in Accounts Payable | -78.00K | 97.00K | -100.00K | -773.00K | -25.00K | 274.00K |
| Change in Other Net Operating Assets | 403.00K | 374.00K | -625.00K | -5.48M | -212.00K | -688.00K |
| Operating Cash Flow | -2.73M | -2.87M | -4.97M | -30.14M | -29.23M | -61.47M |
| Capital Expenditures | -98.00K | -98.00K | -197.00K | -216.00K | -3.32M | |
| Sale of Property, Plant & Equipment | 1.54M | 23.00K | ||||
| Investing Cash Flow | -98.00K | -98.00K | 1.35M | -193.00K | -3.32M | |
| Long-Term Debt Issued | 25.00M | |||||
| Long-Term Debt Repaid | -18.23M | -8.33M | ||||
| Net Debt Issued (Repaid) | 70.00K | -18.23M | -8.33M | 25.00M | ||
| Issuance of Common Stock | 1.91M | 92.00K | 14.74M | 1.04M | ||
| Repurchase of Common Stock | -45.00K | |||||
| Other Financing Activities | -260.00K | |||||
| Financing Cash Flow | 70.00K | 3.26M | -18.14M | 6.37M | 25.78M | |
| Net Cash Flow | -2.75M | 294.00K | -4.97M | -46.93M | -23.06M | -39.02M |
| Free Cash Flow | -2.83M | -2.97M | -4.97M | -30.34M | -29.45M | -64.79M |
| Free Cash Flow Margin | -94,166.67% | -59,340.00% | -49,710.00% | -606,780.00% | -1,007.80% | -16,279.15% |
| Free Cash Flow Per Share | -1.21 | -1.52 | -3.10 | -18.97 | -20.34 | -45.33 |
| Levered Free Cash Flow | -1.57M | -753.62K | -3.30M | -5.10M | -27.95M | -33.39M |
| Unlevered Free Cash Flow | -1.57M | -753.62K | -3.30M | -5.24M | -26.96M | -33.03M |
| Cash Interest Paid | 2.06M | 2.17M | 630.00K | |||
| Change in Working Capital | 327.00K | 473.00K | -729.00K | -6.25M | 870.00K | 3.14M |
Ratios
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Market Capitalization | 4.95M | 7.21M | 3.05M | 16.98M | 155.44M | 233.95M |
| Enterprise Value | 4.83M | 5.27M | 1.37M | 6.21M | 143.18M | 171.86M |
| Last Close Price | 1.95 | 3.23 | 1.91 | 10.60 | 97.36 | 163.50 |
| PS Ratio | 1,651.31 | 1,441.76 | 305.04 | 3,396.28 | 53.20 | 587.82 |
| PB Ratio | 7.44 | 3.35 | 1.48 | 2.69 | 4.03 | 4.03 |
| P/TBV Ratio | 7.60 | 3.35 | 1.48 | 2.69 | 4.03 | 4.03 |
| EV/Sales Ratio | 1,609.98 | 1,054.16 | 136.74 | 1,241.68 | 49.00 | 431.80 |
| Debt / Equity Ratio | 0.51 | 0.51 | ||||
| Net Debt / Equity Ratio | -0.19 | -0.64 | -0.53 | -0.96 | -0.51 | -0.80 |
| Net Debt / EBITDA Ratio | 0.03 | 0.33 | 0.23 | 0.23 | 0.65 | 0.66 |
| Net Debt / FCF Ratio | 0.04 | 0.47 | 0.22 | 0.20 | 0.66 | 0.72 |
| Asset Turnover | 0.00 | 0.00 | 0.00 | 0.00 | 0.04 | 0.00 |
| Quick Ratio | 0.14 | 1.71 | 1.58 | 3.10 | 1.62 | 4.81 |
| Current Ratio | 0.77 | 2.44 | 3.98 | 4.22 | 2.23 | 4.91 |
| Return on Equity (ROE) | -185.95% | -198.10% | -111.80% | -156.66% | -78.11% | -86.52% |
| Return on Assets (ROA) | -81.13% | -92.31% | -54.59% | -48.66% | -25.61% | -37.91% |
| Return on Capital Employed (ROCE) | -622.20% | -196.20% | -233.30% | -451.80% | -80.30% | -92.80% |
| Earnings Yield | -90.69% | -57.93% | -153.39% | -206.93% | -24.27% | -33.66% |
| FCF Yield | -57.03% | -41.16% | -162.96% | -178.66% | -18.95% | -27.69% |
| Buyback Yield / Dilution | -43.66% | -21.68% | -0.11% | -10.50% | -1.27% | -2.27% |